According to the tumor ablation market report, the minimally invasive surgeries or procedures are less painful and can be performed as outpatient procedure, unlike traditional surgeries. These surgeries are emerging as potential replacements for conventional therapeutic cancer surgeries. These surgeries are used for the treatment of various tumors of the prostate gland, lungs, and the liver. Further, robotic navigation technologies that perform ablation procedures more accurately are being incorporated to increase the popularity of these surgeries.
The Global Tumor Ablation Market 2015-2019 report spreads across 70 pages and providing 35 data exhibits is available at:
Segmentation by ablation technology and analysis of the tumor ablation market – Radio frequency, Ultrasound, Cryotherapy and Microwave
In this report, the analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.
Cancer-type segmentation of the tumor ablation market – Liver, Breast, Prostate, Gynecological, Lung and ENT
The analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.
Purchase a Single User License Copy of “Global Tumor Ablation Market 2015-2019” Report at http://www.reportsnreports.com/Purchase.aspx?name=453113 for US $2500.
Competitive landscape and key vendors
Tumor ablation market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.
Key players in the global tumor ablation market: AngioDynamics, Boston Scientific, Ethicon and Medtronic
Other Prominent Vendors in the market are: Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.
Further, tumor ablation market report states that the cost of tumor ablation treatment is directly proportional to the size of the tumor and the number of probes required for the surgery.
Explore other reports on Medical Devices Market at:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email, the details on sales at reportsandreports.com
Company Name: ReportsnReports.com
Contact Person: Ritesh Tiwari
Phone: +1 888 391 5441
Address:UNIT No 802, Tower No. 7, SEZ, Magarpatta city, Hadapsar